A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults
Clinical trial NCT06394167 · COMPLETED
Trial details
- NCT number
- NCT06394167
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-09
- Primary completion
- 2025-02-18
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.